Tung-On Kong

Elham F. Steiner

Wendy L. Devine

David E. Moore

Bindu Ann George Palapura

Kristina M. Hanson

Andrew M. Moshos

Jody Karol

Mark A. Hayden

Sean M. Anderson

Shannon P. Gillespie McComb

Bruce M. Wexler

Jack B. Blumenfeld

Jeremy A. Tigan

Isaac S. Ashkenazi

Anthony D. Raucci

Christopher P. Hill

Justin Fleischacker

Mark R. Sperling

Stephen Kruse

ANDA filing triggers clash over Heron's Cinvanti® patents, with Mylan's generic accused on 'physically stable' injectable emulsion claims for chemo drugs.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5 A
Jeremy A. Tigan	L5 A
Jack B. Blumenfeld	L5 A
Anthony D. Raucci	L5 A
Paul Hastings LLP	L4 D
Bruce M. Wexler	L5 A
Isaac S. Ashkenazi	L2 B
Mark R. Sperling	L2 C
Christopher P. Hill	L1 B
Justin Fleischacker	-- -- --
Stephen Kruse	-- -- --

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5 A
Wendy L. Devine	L5 A
Tung-On Kong	L4 A
Elham F. Steiner	L4 B
Kristina M. Hanson	L2 A
Mark A. Hayden	L2 B
Jody Karol	L1 C
Sean M. Anderson	-- -- --
Shannon P. Gillespie McComb	-- -- --
Potter Anderson & Corroon LLPLocal	L5 A
David E. Moore	L5 A
Bindu Ann George Palapura	L5 A
Andrew M. Moshos	L4 A

1:23-cv-01015

Heron Therap Inc v. Mylan Pharma Inc